4 years ago

Orbit Discovery Secures $7.6 Million Funding Led by Oxford Sciences Innovation

  • Orbit Discovery, a UK-based biopharmaceutical company focused on discovering candidate peptide therapeutics, has raised $7.6 million in funding

  • The financing was led by Oxford Sciences Innovation, with participation from Borealis Ventures, Perivoli Innovations, and other institutional and individual investors, including Kapil Dev Joory

  • The proceeds will be used to accelerate the company's growth

  • Orbit Discovery's novel bead-based and microfluidic technology platform enables the screening of peptide libraries for target binding and subsequent activity in cell-based functional assays

  • This allows the company to identify active peptides against both soluble proteins and membrane bound targets such as GPCRs.

      • ProblemBiopharmaceutical

      "identifying active peptides against target binding"

      Solution

      "novel bead-based and microfluidic technology platform enables the screening of peptide libraries"

      Covered on